{"id":"https://openalex.org/W2591076216","doi":"https://doi.org/10.1200/jco.2014.32.4_suppl.305","title":"Phase II study of neoadjuvant sorafenib plus cisplatin and gemcitabine (S-CG) for patients with muscle-invasive transitional cell carcinoma of the bladder (MIBC): Results at the end of first stage (NCT01222676).","display_name":"Phase II study of neoadjuvant sorafenib plus cisplatin and gemcitabine (S-CG) for patients with muscle-invasive transitional cell carcinoma of the bladder (MIBC): Results at the end of first stage (NCT01222676).","alternate_titles":[],"publication_year":2014,"publication_date":"2014-02-01","ids":{"openalex":"https://openalex.org/W2591076216","doi":"https://doi.org/10.1200/jco.2014.32.4_suppl.305","mag":"2591076216"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.4_suppl.305","doi":"https://doi.org/10.1200/jco.2014.32.4_suppl.305","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.4_suppl.305","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2591076216"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083331837","display_name":"Andrea Necchi","orcid":"https://orcid.org/0000-0002-3007-2756","observed_orcids":["https://orcid.org/0000-0002-3007-2756"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Andrea Necchi","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090061046","display_name":"Patrizia Giannatempo","orcid":"https://orcid.org/0000-0002-3358-4466","observed_orcids":["https://orcid.org/0000-0002-3358-4466"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Patrizia Giannatempo","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090715927","display_name":"Luigi Mariani","orcid":"https://orcid.org/0000-0001-6208-4084","observed_orcids":["https://orcid.org/0000-0001-6208-4084"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luigi Mariani","raw_affiliation_strings":["Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005962316","display_name":"Emanuela Fina","orcid":"https://orcid.org/0000-0002-9837-4320","observed_orcids":["https://orcid.org/0000-0002-9837-4320"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Emanuela Fina","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067994961","display_name":"Nicola Nicolai","orcid":"https://orcid.org/0000-0002-5718-2699","observed_orcids":["https://orcid.org/0000-0002-5718-2699"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Nicola Nicolai","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038502087","display_name":"Marzia Pennati","orcid":"https://orcid.org/0000-0002-6181-2681","observed_orcids":["https://orcid.org/0000-0002-6181-2681"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marzia Pennati","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075803217","display_name":"Nadia Zaffaroni","orcid":"https://orcid.org/0000-0002-4669-0890","observed_orcids":["https://orcid.org/0000-0002-4669-0890"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Nadia Zaffaroni","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012466586","display_name":"Elena Far\u00e8","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elena Far\u00e8","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110087480","display_name":"Luigi Piva","orcid":"https://orcid.org/0009-0004-9306-5248","observed_orcids":["https://orcid.org/0009-0004-9306-5248"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luigi Piva","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085121255","display_name":"Davide Biasoni","orcid":"https://orcid.org/0000-0001-6552-2895","observed_orcids":["https://orcid.org/0000-0001-6552-2895"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Davide Biasoni","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058115974","display_name":"Mario Achille Catanzaro","orcid":"https://orcid.org/0000-0002-0326-6598","observed_orcids":["https://orcid.org/0000-0002-0326-6598"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mario Catanzaro","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004236203","display_name":"Tullio Torelli","orcid":"https://orcid.org/0000-0002-1866-1056","observed_orcids":["https://orcid.org/0000-0002-1866-1056"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Tullio Torelli","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024954730","display_name":"Silvia Stagni","orcid":"https://orcid.org/0000-0003-0089-4713","observed_orcids":["https://orcid.org/0000-0003-0089-4713"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Silvia Stagni","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044990634","display_name":"Massimo Maffezzini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Massimo Maffezzini","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086507632","display_name":"Maurizio Colecchia","orcid":"https://orcid.org/0000-0003-1914-0743","observed_orcids":["https://orcid.org/0000-0003-1914-0743"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maurizio Colecchia","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016473783","display_name":"Biagio Paolini","orcid":"https://orcid.org/0000-0001-7535-7715","observed_orcids":["https://orcid.org/0000-0001-7535-7715"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Biagio Paolini","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016673044","display_name":"Vera Cappelletti","orcid":"https://orcid.org/0000-0002-9709-0676","observed_orcids":["https://orcid.org/0000-0002-9709-0676"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Vera Cappelletti","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026775250","display_name":"Maria Grazia Daidone","orcid":"https://orcid.org/0000-0002-4786-1321","observed_orcids":["https://orcid.org/0000-0002-4786-1321"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Grazia Daidone","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109100135","display_name":"Alessandro M. Gianni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessandro M. Gianni","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milano, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milano, Milan, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I4210156707"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080811290","display_name":"Roberto Salvioni","orcid":"https://orcid.org/0000-0001-7581-5421","observed_orcids":["https://orcid.org/0000-0001-7581-5421"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Roberto Salvioni","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"4_suppl","first_page":"305","last_page":"305"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12695","display_name":"Urinary and Genital Oncology Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.8730000257492065},{"id":"https://openalex.org/keywords/muscle-invasive-bladder-cancer","display_name":"muscle-invasive bladder cancer","score":0.9089999794960022},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":1.0},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9409999847412109},{"id":"https://openalex.org/keywords/radical-cystectomy","display_name":"radical cystectomy","score":0.8970000147819519},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.7129999995231628},{"id":"https://openalex.org/keywords/circulating-tumor-cells","display_name":"circulating tumor cells","score":0.5009999871253967},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.4830000102519989},{"id":"https://openalex.org/keywords/hand-foot-syndrome","display_name":"hand-foot syndrome","score":0.7110000252723694},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.7540000081062317},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.4449999928474426},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.5249999761581421},{"id":"https://openalex.org/keywords/recurrence-free-survival","display_name":"recurrence-free survival","score":0.5189999938011169},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5019999742507935}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9246985912322998},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.7447888851165771},{"id":"https://openalex.org/C2775910329","wikidata":"https://www.wikidata.org/wiki/Q245995","display_name":"Cystectomy","level":4,"score":0.7314753532409668},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.6162689328193665},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.592214822769165},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5731534957885742},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.5439990758895874},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.540265679359436},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5226133465766907},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4701022505760193},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.4500279724597931},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.41005662083625793},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3722054362297058},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32386648654937744},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.20796146988868713},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.1561594307422638},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.4_suppl.305","doi":"https://doi.org/10.1200/jco.2014.32.4_suppl.305","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.4_suppl.305","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2316975190","https://openalex.org/W2604073114","https://openalex.org/W2754362158","https://openalex.org/W2603324978","https://openalex.org/W4236041929","https://openalex.org/W2515147712","https://openalex.org/W2764167279","https://openalex.org/W2942136522","https://openalex.org/W4244288707","https://openalex.org/W7133207172"],"abstract_inverted_index":{"305":[0],"Background:":[1],"The":[2],"small,":[3],"yet":[4],"significant,":[5],"survival":[6],"advantage":[7],"with":[8,40,110,298,325],"neoadjuvant":[9],"chemotherapy":[10],"in":[11,29,94,108,199,206,212,315,323,338],"MIBC":[12,42],"needs":[13],"to":[14,75,100,140,260,272,292,311,332],"be":[15,92],"improved.":[16],"A":[17],"rationale":[18],"exists":[19],"for":[20,268],"inhibiting":[21],"the":[22,95,146,232,252,334,346],"RAF/MEK/ERK":[23],"pathway":[24],"and":[25,53,60,125,148,162,187,210,229,250,308,351],"investigating":[26],"S-CG":[27],"combination":[28],"an":[30],"ongoing":[31],"open-label,":[32],"single-group,":[33],"phase":[34],"II":[35],"trial.":[36],"Methods:":[37],"Patients":[38],"(pts)":[39],"T2-4N0":[41],"received":[43],"4":[44],"cycles":[45],"of":[46,103,113,196,223,239,263,281,289,336],"cisplatin":[47],"70":[48],"mg/m2":[49,56],"on":[50,57],"day":[51,58,73,261],"1":[52,59,74],"gemcitabine":[54],"1000":[55],"8,":[61],"every":[62],"3":[63,207,242,294],"weeks.":[64],"Sorafenib":[65,330],"400":[66],"mg":[67],"q12h":[68],"was":[69,116,122,153,266,321],"administered":[70],"daily":[71],"from":[72,138,258,304],"cystectomy.":[76,177],"An":[77],"optimal":[78],"2-stage":[79],"Simon\u2019s":[80],"design":[81],"is":[82,131],"applied.":[83,123],"6":[84,167,225],"pathologic":[85],"complete":[86],"responses":[87],"(pT0,":[88],"primary":[89],"endpoint)":[90],"should":[91,344],"observed":[93,267],"first":[96],"stage":[97],"before":[98],"moving":[99],"full":[101],"enrollment":[102],"45":[104],"cases.":[105],"Residual":[106],"carcinoma":[107],"situ":[109],"no":[111],"evidence":[112],"invasive":[114],"tumor":[115,127],"considered":[117],"as":[118],"pT0.":[119],"Intention-to-treat":[120],"analysis":[121,130],"Biomarker":[124],"circulating":[126,316],"cell":[128],"(CTC)":[129],"ongoing.":[132],"Results:":[133],"23":[134],"pts":[135,168,174,179,189,201,214,217,243,276,296],"were":[136],"enrolled":[137],"04/11":[139],"07/13.":[141],"Thus":[142],"far,":[143],"21":[144],"completed":[145],"treatment":[147],"are":[149,254],"evaluable.":[150],"Median":[151,256],"age":[152],"61yrs":[154],"(IQR:":[155],"54-66).":[156],"11":[157],"had":[158,169,184,245,277,301],"T2,":[159],"9":[160,216],"T3,":[161],"one":[163],"a":[164,185,190,220,226,235,246,278,302],"T4":[165],"disease.":[166],"hydronephrosis":[170],"at":[171],"presentation.":[172],"19":[173],"underwent":[175],"radical":[176],"Eight":[178],"(38.1%,":[180],"95%":[181],"CI:":[182],"18.1-61.6%)":[183],"pT0":[186,295],"2":[188,213,230],"pT<2.":[191],"G3-4":[192],"side":[193],"effects":[194],"consisted":[195],"hematologic":[197],"toxicity":[198],"8":[200,262,290],"(38%),":[202],"hand-foot":[203],"syndrome":[204],"(HFS)":[205],"pts,":[208],"hypertension":[209],"asthenia":[211],"each.":[215],"(42.8%)":[218],"needed":[219],"temporary":[221],"interruption":[222],"sorafenib,":[224],"dose":[227],"reduction,":[228],"suspended":[231],"drug.":[233],"After":[234],"median":[236],"follow":[237],"up":[238],"12.6":[240],"months,":[241],"(14.3%)":[244],"recurrence":[247],"or":[248],"progression":[249,327],"died,":[251],"remaining":[253],"disease-free.":[255],"increase":[257],"baseline":[259,288,305],"second":[264],"cycle":[265],"VEGF":[269],"levels":[270,318],"(85.8":[271],"119.5":[273],"pg/mL).":[274],"All":[275],"stepwise":[279],"reduction":[280],"CTC":[282,320],"count/5mL":[283],"blood":[284],"by":[285,319],"ScreenCell":[286],"(median":[287],"[0-40]":[291],"2[0-6]).":[293],"starting":[297],"cT3b":[299],"disease":[300,326],"decrease":[303],"21,":[306],"10,":[307],"40":[309],"cells":[310],"\u22643":[312],"cells.":[313],"Increase":[314],"EpCAM\u00b1Muc-1":[317],"seen":[322],"accordance":[324],"(PD).":[328],"Conclusions:":[329],"seems":[331],"enhance":[333],"efficacy":[335],"CG":[337],"this":[339],"setting.":[340],"If":[341],"confirmed,":[342],"research":[343],"delineate":[345],"mechanisms":[347],"behind":[348],"clinical":[349],"benefit":[350],"characterize":[352],"PD.":[353],"Clinical":[354],"trial":[355],"information:":[356],"NCT01222676.":[357]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2591076216","counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2017-03-03T00:00:00"}
